4 results match your criteria: "Weill Cornell Medical College of New York-Presbyterian Hospital[Affiliation]"

Tethered vitreous seeds following intravitreal melphalan for retinoblastoma.

JAMA Ophthalmol

August 2014

Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York2Department of Ophthalmology, Weill Cornell Medical College, New York, New York.

View Article and Find Full Text PDF

Death by water: precautionary water submersion for intravitreal injection of retinoblastoma eyes.

Open Ophthalmol J

June 2014

Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA ; Department of Ophthalmology, Weill Cornell Medical College of New York-Presbyterian Hospital, New York, NY, USA.

There is growing interest in intravitreal injections of chemotherapy for retinoblastoma. However, concerns for potential tumor seeding through the needle track has prompted the use of risk-reducing precautionary methods. Presented here is a novel technique, which can be easily replicated, requires minimal sophisticated equipment and with laboratory data supporting its concept.

View Article and Find Full Text PDF

Electroretinogram monitoring of dose-dependent toxicity after ophthalmic artery chemosurgery in retinoblastoma eyes: six year review.

PLoS One

December 2014

Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America ; Department of Ophthalmology, Mount Sinai School of Medicine, New York, New York, United States of America.

Purpose: To report electroretinogram responses of retinoblastoma children under anesthesia before and after treatment with chemotherapeutic drugs (melphalan, topotecan, carboplatin) delivery by ophthalmic artery chemosurgery (OAC).

Methods: A cohort study of 81 patients with retinoblastoma treated with OAC. All patients treated with OAC at our center through May 2012 for whom the requisite ERG data were available are included in the analysis.

View Article and Find Full Text PDF

Background: Intra-arterial (i.a.) chemotherapy has more risks of procedural complications in neonates and young infants.

View Article and Find Full Text PDF